Related Experiment Video
Updated: Mar 17, 2026

05:05
Author Spotlight: Integrating Eastern and Western Medicine for Treatment of Granulomatous Mastitis
Published on: May 3, 2024
2.1K
[Idiopathic granulomatous mastitis - a rare inflammatory condition]
Helen Poli1, Ceren Boyaci2, Seda Özbek3
1bitr överläkare i kirurgi, bröstsektionen, kirurgkliniken, Södersjukhuset, Stockholm.
Summary
Idiopathic granulomatous mastitis (IGM), a rare breast condition, requires a multidisciplinary approach for diagnosis and management. This guideline offers evidence-based strategies for investigating and treating IGM, aiming to improve patient outcomes.
Area of Science:
- Breast Health
- Inflammatory Conditions
- Rare Diseases
Background:
- Idiopathic granulomatous mastitis (IGM) is a rare, chronic inflammatory breast disease of unknown cause.
- It primarily affects women of childbearing age, presenting with abscesses and potential breast deformation.
- Differential diagnoses include breast cancer and tuberculosis, necessitating accurate identification.
Purpose of the Study:
- To develop a guideline for the investigation and management of suspected Idiopathic granulomatous mastitis (IGM).
- To provide physicians with evidence-based strategies for diagnosing and treating IGM.
- To establish a multidisciplinary approach for optimal patient care.
Main Methods:
- A literature search was conducted in NCBI Pubmed, including thirty relevant studies.
- Flowcharts were developed for IGM investigation and treatment protocols.
- Diagnostic methods include cultures, DNA sequencing, biopsies, and blood tests.
Main Results:
- Recommended investigation includes bacterial/fungal cultures, DNA sequencing, core needle biopsy, blood tests, and skin punch biopsy.
- Ultrasound-guided drainage is advised for abscesses; surgery should be avoided.
- Treatment involves topical corticosteroids initially, followed by oral corticosteroids and methotrexate if needed.
Conclusions:
- IGM management requires a specialized multidisciplinary team due to its complexity.
- The guideline provides a structured approach to diagnosis and treatment, emphasizing conservative measures.
- An upcoming IGM registry study is expected to further enhance understanding and management.
Related Concept Videos
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K

